OpenFilings
Moleculin Biotech, Inc.
Form
8-K
Report Period
2026-10-09
Date Filed
2026-10-09
Time Filed
17:15:50
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
FORM 8-K
EXHIBIT 10.1 - MOLECULIN BIOTECH, INC. 2024 STOCK PLAN (AS AMENDED AND RESTATED)
Filing on SEC Edgar